Literature DB >> 26022558

Estimating the concordance probability in a survival analysis with a discrete number of risk groups.

Glenn Heller1, Qianxing Mo2.   

Abstract

A clinical risk classification system is an important component of a treatment decision algorithm. A measure used to assess the strength of a risk classification system is discrimination, and when the outcome is survival time, the most commonly applied global measure of discrimination is the concordance probability. The concordance probability represents the pairwise probability of lower patient risk given longer survival time. The c-index and the concordance probability estimate have been used to estimate the concordance probability when patient-specific risk scores are continuous. In the current paper, the concordance probability estimate and an inverse probability censoring weighted c-index are modified to account for discrete risk scores. Simulations are generated to assess the finite sample properties of the concordance probability estimate and the weighted c-index. An application of these measures of discriminatory power to a metastatic prostate cancer risk classification system is examined.

Entities:  

Keywords:  C-index; Concordance probability estimate; Discrimination; Inverse probability censoring weight; Risk classification

Mesh:

Year:  2015        PMID: 26022558      PMCID: PMC4886856          DOI: 10.1007/s10985-015-9330-3

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  7 in total

1.  Investigating the effects of ties on measures of concordance.

Authors:  Guofen Yan; Tom Greene
Journal:  Stat Med       Date:  2008-09-20       Impact factor: 2.373

2.  Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring.

Authors:  Thomas A Gerds; Michael W Kattan; Martin Schumacher; Changhong Yu
Journal:  Stat Med       Date:  2012-11-22       Impact factor: 2.373

3.  On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Authors:  Hajime Uno; Tianxi Cai; Michael J Pencina; Ralph B D'Agostino; L J Wei
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

4.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

5.  Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival.

Authors:  Daniel C Danila; Aseem Anand; Nikolaus Schultz; Glenn Heller; Mingliang Wan; Clifford C Sung; Charles Dai; Raya Khanin; Martin Fleisher; Hans Lilja; Howard I Scher
Journal:  Eur Urol       Date:  2013-07-26       Impact factor: 20.096

Review 6.  Circulating tumor cells as biomarkers in prostate cancer.

Authors:  Daniel C Danila; Martin Fleisher; Howard I Scher
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

7.  Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

Authors:  Howard I Scher; Xiaoyu Jia; Johann S de Bono; Martin Fleisher; Kenneth J Pienta; Derek Raghavan; Glenn Heller
Journal:  Lancet Oncol       Date:  2009-02-11       Impact factor: 41.316

  7 in total
  15 in total

1.  An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.

Authors:  Iain J Nixon; Laura Y Wang; Jocelyn C Migliacci; Antoine Eskander; Michael J Campbell; Ahmad Aniss; Lilah Morris; Fernanda Vaisman; Rossana Corbo; Denise Momesso; Mario Vaisman; Andre Carvalho; Diana Learoyd; William D Leslie; Richard W Nason; Deborah Kuk; Volkert Wreesmann; Luc Morris; Frank L Palmer; Ian Ganly; Snehal G Patel; Bhuvanesh Singh; R Michael Tuttle; Ashok R Shaha; Mithat Gönen; K Alok Pathak; Wen T Shen; Mark Sywak; Luis Kowalski; Jeremy Freeman; Nancy Perrier; Jatin P Shah
Journal:  Thyroid       Date:  2016-02-25       Impact factor: 6.568

2.  A Nomogram to Predict Prognosis in Malignant Pleural Mesothelioma.

Authors:  Shuai Wang; Ke Ma; Zongwei Chen; Xiaodong Yang; Fenghao Sun; Yulin Jin; Yu Shi; Wei Jiang; Qun Wang; Cheng Zhan
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

3.  Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer.

Authors:  Blake A Spindler; John R Bergquist; Cornelius A Thiels; Elizabeth B Habermann; Scott R Kelley; David W Larson; Kellie L Mathis
Journal:  J Gastrointest Surg       Date:  2017-03-13       Impact factor: 3.452

4.  Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer.

Authors:  Cuong P Duong; Nicholas J Clemons; Carlos S Cabalag; Owen W J Prall; John Ciciulla; Laurence A Galea; Niko Thio; Madawa Jayawardana; Trishe Y M Leong; Julia V Milne; Kenji M Fujihara; Lynn Chong; Michael W Hii; Gisela Mir Arnau; Paul J Neeson; Wayne A Phillips
Journal:  Ann Surg Oncol       Date:  2022-10-02       Impact factor: 4.339

5.  Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung.

Authors:  Tomonari Oki; Keiju Aokage; Shogo Nomura; Kenta Tane; Tomohiro Miyoshi; Norihiko Shiiya; Kazuhito Funai; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-22       Impact factor: 4.553

6.  Concordance probability as a meaningful contrast across disparate survival times.

Authors:  Sean M Devlin; Glenn Heller
Journal:  Stat Methods Med Res       Date:  2020-12-09       Impact factor: 3.021

7.  Liver Transplantation for Extended Criteria Hepatocellular Carcinoma Using Stable Response to Locoregional Therapy and Alpha-Fetoprotein as Selection Criteria.

Authors:  Markus Bo Schoenberg; Hubertus Johann Wolfgang Anger; Julian Nikolaus Bucher; Gerald Denk; Enrico Narciso De Toni; Max Seidensticker; Joachim Andrassy; Martin Kurt Angele; Jens Werner; Markus Otto Guba
Journal:  Visc Med       Date:  2020-03-20

8.  A novel deep autoencoder based survival analysis approach for microarray dataset.

Authors:  Hanaa Torkey; Hanaa Salem; Mostafa Atlam; Nawal El-Fishawy
Journal:  PeerJ Comput Sci       Date:  2021-04-21

9.  Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.

Authors:  Sofia Molina; Gabriela Martinez-Zayas; Paula V Sainz; Cheuk H Leung; Liang Li; Horiana B Grosu; Roberto Adachi; David E Ost
Journal:  Chest       Date:  2021-05-11       Impact factor: 10.262

10.  Nomogram to predict thymoma prognosis: A population-based study of 1312 cases.

Authors:  Mengnan Zhao; Jiacheng Yin; Xiaodong Yang; Tian Jiang; Tao Lu; Yiwei Huang; Ming Li; Xinyu Yang; Miao Lin; Hao Niu; Cheng Zhan; Mingxiang Feng; Qun Wang
Journal:  Thorac Cancer       Date:  2019-04-07       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.